Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Herbamin Biolab IVS
IVS
Dissolved
Advertising protection
CVR 39573881
Rendevej 1, 4540
Fårevejle
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 8 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Herbamin Biolab IVS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (3)
ZG
Ziggy Gert Willumsen
Chief Executive Officer
Chief Executive Officer
2018 – 2021
TB
Torben Brems Desler
Management
Management
2018 – 2021
FO
Flemming Olsen
Management
Management
2018 – 2021
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Ziggy Gert Willumsen — 33.33–49.99%
Torben Brems Desler — 20–24.99%
Flemming Olsen — 33.33–49.99%
87–100%
Shareholder
Type
Ownership
Votes
Since
Ziggy Gert Willumsen
Individual
33.33–49.99%
33.33–49.99%
2018
Torben Brems Desler
Individual
20–24.99%
20–24.99%
2018
Flemming Olsen
Individual
33.33–49.99%
33.33–49.99%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Herbamin Biolab IVS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
